Maravai LifeSciences Holdings (STU:MAR) Receivables Turnover : 1.41 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Maravai LifeSciences Holdings Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Maravai LifeSciences Holdings's Revenue for the three months ended in Mar. 2024 was €59.0 Mil. Maravai LifeSciences Holdings's average Accounts Receivable for the three months ended in Mar. 2024 was €41.9 Mil. Hence, Maravai LifeSciences Holdings's Receivables Turnover for the three months ended in Mar. 2024 was 1.41.

Maravai LifeSciences Holdings Receivables Turnover Historical Data

The historical data trend for Maravai LifeSciences Holdings's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maravai LifeSciences Holdings Receivables Turnover Chart

Maravai LifeSciences Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

8.51

8.03

9.69

7.10

2.93

Maravai LifeSciences Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															0.80	1.30	1.42	1.46	1.41

Competitive Comparison of Maravai LifeSciences Holdings's Receivables Turnover

For the Biotechnology subindustry, Maravai LifeSciences Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maravai LifeSciences Holdings's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Maravai LifeSciences Holdings's Receivables Turnover falls into.

Maravai LifeSciences Holdings Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Maravai LifeSciences Holdings's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	264.963	/ (	(130.861	+	50.073)	/	2 )
=	264.963	/	90.467
=	2.93

Maravai LifeSciences Holdings's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	59.045	/ (	(50.073	+	33.75)	/	2 )
=	59.045	/	41.9115
=	1.41

Maravai LifeSciences Holdings (STU:MAR) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Maravai LifeSciences Holdings Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Maravai LifeSciences Holdings's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Maravai LifeSciences Holdings (STU:MAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maravai LifeSciences Holdings Inc (STU:MAR) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

MRVI:USA MRVI:Mexico

Address

10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121

Website

https://www.maravai.com

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.